A Study to Assess the Effects of Multiple-Dose Probenecid on the Multiple-Dose Pharmacokinetics of Canagliflozin in Healthy Volunteers

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of this study is to assess the effects of multiple doses of probenecid on the multiple-dose pharmacokinetics of canagliflozin and its metabolites in healthy volunteers. Safety and tolerability will also be assessed.

Key facts

Study ID

NCT01428284

Run by

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

People needed

14

Starts

2011-08-01

Expected to finish

2011-10-01

Last updated by the study team

2012-02-17

Who can join

Age: 15 and older, up to 55. Sex: any. Healthy volunteers: accepted.

Where it is running

• Study site — Overland Park, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.